Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

Sikander Ailawadhi, A. Swaika, P. Razavi, D. Yang, Asher A Chanan Khan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Second primary malignancies (SPMs) among multiple myeloma (MM) patients have been reported with an estimated incidence varying from 1 to 15%. We have previously reported that significant disparity exists in MM survival across patients of different ethnicities. We undertook a Surveillance Epidemiology and End Results-based analysis to describe the incidence of SPMs among MM patients of different ethnicities, to explore the variable impact that SPMs might have on MM outcomes of patients across racial subgroups. We found that the risk of developing SPMs among MM patients is variable depending on the patient's ethnic background. This warrants further exploration of the impact of SPMs on outcomes of MM patients across different racial subgroups, especially in the form of prospective data collection and analyses.

Original languageEnglish (US)
Article numbere243
JournalBlood Cancer Journal
Volume4
Issue number9
DOIs
StatePublished - Jan 1 2014

Fingerprint

Second Primary Neoplasms
Multiple Myeloma
Incidence
Epidemiology
Survival

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups. / Ailawadhi, Sikander; Swaika, A.; Razavi, P.; Yang, D.; Chanan Khan, Asher A.

In: Blood Cancer Journal, Vol. 4, No. 9, e243, 01.01.2014.

Research output: Contribution to journalArticle

@article{cb846458806347e0871a7af6bba5f78c,
title = "Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups",
abstract = "Second primary malignancies (SPMs) among multiple myeloma (MM) patients have been reported with an estimated incidence varying from 1 to 15{\%}. We have previously reported that significant disparity exists in MM survival across patients of different ethnicities. We undertook a Surveillance Epidemiology and End Results-based analysis to describe the incidence of SPMs among MM patients of different ethnicities, to explore the variable impact that SPMs might have on MM outcomes of patients across racial subgroups. We found that the risk of developing SPMs among MM patients is variable depending on the patient's ethnic background. This warrants further exploration of the impact of SPMs on outcomes of MM patients across different racial subgroups, especially in the form of prospective data collection and analyses.",
author = "Sikander Ailawadhi and A. Swaika and P. Razavi and D. Yang and {Chanan Khan}, {Asher A}",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/bcj.2014.63",
language = "English (US)",
volume = "4",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

AU - Ailawadhi, Sikander

AU - Swaika, A.

AU - Razavi, P.

AU - Yang, D.

AU - Chanan Khan, Asher A

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Second primary malignancies (SPMs) among multiple myeloma (MM) patients have been reported with an estimated incidence varying from 1 to 15%. We have previously reported that significant disparity exists in MM survival across patients of different ethnicities. We undertook a Surveillance Epidemiology and End Results-based analysis to describe the incidence of SPMs among MM patients of different ethnicities, to explore the variable impact that SPMs might have on MM outcomes of patients across racial subgroups. We found that the risk of developing SPMs among MM patients is variable depending on the patient's ethnic background. This warrants further exploration of the impact of SPMs on outcomes of MM patients across different racial subgroups, especially in the form of prospective data collection and analyses.

AB - Second primary malignancies (SPMs) among multiple myeloma (MM) patients have been reported with an estimated incidence varying from 1 to 15%. We have previously reported that significant disparity exists in MM survival across patients of different ethnicities. We undertook a Surveillance Epidemiology and End Results-based analysis to describe the incidence of SPMs among MM patients of different ethnicities, to explore the variable impact that SPMs might have on MM outcomes of patients across racial subgroups. We found that the risk of developing SPMs among MM patients is variable depending on the patient's ethnic background. This warrants further exploration of the impact of SPMs on outcomes of MM patients across different racial subgroups, especially in the form of prospective data collection and analyses.

UR - http://www.scopus.com/inward/record.url?scp=84927721968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927721968&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.63

DO - 10.1038/bcj.2014.63

M3 - Article

C2 - 25192415

AN - SCOPUS:84927721968

VL - 4

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 9

M1 - e243

ER -